Disclosures I have nothing to disclose. Neoplastic joint disease - - PowerPoint PPT Presentation

disclosures
SMART_READER_LITE
LIVE PREVIEW

Disclosures I have nothing to disclose. Neoplastic joint disease - - PowerPoint PPT Presentation

Disclosures I have nothing to disclose. Neoplastic joint disease (and tumor-like conditions) Andrew Horvai, MD, PhD Clinical Professor, Pathology Synovial lipoma(tosis) ( Lipoma arborescens ) Introduction Clinical o o Knee > wrist, hip


slide-1
SLIDE 1

1

Neoplastic joint disease

(and tumor-like conditions)

Andrew Horvai, MD, PhD Clinical Professor, Pathology

Disclosures

I have nothing to disclose.

Introduction

  • Virtually any neoplasm of bone can secondarily involve joint

imaging essential to exclude

  • Primary neoplasms of joints
  • Tend to involve cavitated joints (synovium)
  • Most are benign
  • Masses of nonsynovial joints are usually degenerative
  • Synovial neoplasms
  • Lipoma(tosis)
  • Chondroma(tosis)
  • Hemangioma
  • Tenosynovial giant cell tumor
  • “Synovial” sarcoma

Synovial lipoma(tosis) (Lipoma arborescens)

  • Clinical
  • Knee > wrist, hip
  • Slow, painless swelling
  • Recurrence very rare
  • Imaging
  • Does not erode bone
  • MRI – increased nodularity and fat signal in synovium
  • Pathology
  • Nodular, bright yellow synovium
  • Replacement of subsynovial connective tissue with mature adipose tissue,

villous architecture

  • May contain lipoblasts
  • Lined by single layer of synoviocytes
  • Differential diagnosis
  • Normal synovial fat (has more collagen between fat cells)
  • Atypical lipomatous tumor (very rare in synovium)
  • Hoffa’s disease (probably same lesion, located in infrapatellar fat pad)
slide-2
SLIDE 2

2 Synovial lipoma

T2 FS

Does not erode bone

1 cm

Synovial lipomatosis Synovial lipomatosis Synovial lipomatosis

slide-3
SLIDE 3

3

Synovial chondroma(tosis)

  • Clinical
  • 3rd-5th decade
  • Knee, shoulder, large joints
  • Rare recurrence
  • Malignant transformation ~1%
  • Imaging
  • If calcified, plain film shows multiple cloudy or ring calcs
  • Can erode cortex
  • MRI, lobulated, bright on T2
  • Pathology
  • Multiple nodules of blue cartilage, + lined by synovium
  • Clustering of chondrocytes
  • Nucleomegaly and binucleation common, mitoses absent
  • Necrosis OK
  • Differential diagnosis
  • Chondro-osseous loose body
  • Soft tissue chondroma (closely related if not same)
  • Synovial chondrosarcoma (secondary chondrosarcoma)

Synovial chondromatosis

Synovial chondromatosis: multiple nodules, eroding articular cartilage Synovial chondromatosis: clustering + endochondral ossification

slide-4
SLIDE 4

4

Synovial chondromatosis Synovial chondromatosis Synovial chondromatosis

Synovial chondromatosis, secondary chondrosarcoma

slide-5
SLIDE 5

5

Synovial chondromatosis, secondary chondrosarcoma

Chondro-osseous loose body

Chondro-osseous loose body: Hyaline and fibrocartilage, irregular calcifications Chondro-osseous loose body

slide-6
SLIDE 6

6

Synovial “hemangioma”

  • Clinical
  • Vascular malformation not a true vascular neoplasm
  • Children > Adults, knee most common
  • Most asymptomatic, or slow swelling, decreased range of motion
  • Cured by excision
  • Imaging
  • Plain film may suggest effusion (nonspecific)
  • MRI – T2 bright serpentine structures, fluid-fluid levels
  • Pathology
  • Vascular channels of varying caliber, increased density beneath normal or

hyperplastic synovium

  • Increased fat
  • No atypia or mitoses
  • Differential diagnosis
  • Chronic hemarthrosis (grossly)
  • Diffuse tenosynovial giant cell tumor (imaging)

T2 FS

Synovial “hemangioma” Synovial “hemangioma”

Synovial hemangioma

slide-7
SLIDE 7

7

Synovial hemangioma Synovial hemangioma

Tenosynovial giant cell tumor

  • Clinical
  • Adults, knee, wrist, digits, shoulder
  • Slow growing joint swelling, locking
  • Recurrence risk ~ growth pattern
  • Imaging
  • Soft tissue mass, may erode bone
  • “Bloom” on MRI, T2 bright, sometimes T1 bright also
  • Pathology
  • Polymorphic: Histiocytes, multinucleated giant cells, spindly fibroblasts,

siderophages, foam cells, chronic inflammation

  • Central fibrosis in older lesions
  • Mitoses may be brisk not atypical
  • Differential diagnosis
  • Giant cell tumor of low malignant potential (soft tissue analog of GCT of

bone)

  • Chronic hemarthrosis
  • Malignant tenosynovial giant cell tumor

Localized Diffuse Gender M > F F > M Joints Small, hand Large, knee Size < 5 cm >10 cm Recurrence 4-30% 30-50% IHC CD68, desmin CD68, desmin

Tenosynovial giant cell tumor

slide-8
SLIDE 8

8

Diffuse, T2 FS Localized, T2 FS

Tenosynovial giant cell tumor

Horvai A, Robbins Basic Pathology, Elsevier, 2017

Tenosynovial giant cell tumor: Diffuse

Tenosynovial giant cell tumor: Diffuse Tenosynovial giant cell tumor: Diffuse

slide-9
SLIDE 9

9

Tenosynovial giant cell tumor: diffuse Tenosynovial giant cell tumor: diffuse

Tensynovial giant cell tumor: localized

Tenosynovial giant cell tumor: diffuse Tenosynovial giant cell tumor: localized

slide-10
SLIDE 10

10

Tenosynovial giant cell tumor: localized Tenosynovial giant cell tumor: localized Tenosynovial giant cell tumor: localized Tenosynovial giant cell tumor: localized

slide-11
SLIDE 11

11

Tenosynovial giant cell tumor: localized Tenosynovial giant cell tumor: localized Tenosynovial giant cell tumor: desmin

Tenosynovial giant cell tumor

  • Same genetic abnormality in both subtypes (COL6A3:CSF1)
  • Diffuse and localized type related to anatomic compartment

rather than biology

  • Provides mechanism of pathogenesis analogous to giant cell

tumor of bone

West RB et al. PNAS, 2006 103(3) 690–695.

slide-12
SLIDE 12

12

Synovial sarcoma

Jones SF, Whitman RC. Ann Surg. 1914;60(4):440-50.

Synovial sarcoma

  • Clinical
  • Young adults (peak), wide age range
  • 80% extremity, knee common but not intra-articular, can arise anywhere
  • 5 year survival 36-76%, chemotherapy + surgery
  • Pathology
  • Monophasic (70%): uniform spindle cells, short fascicles, herringbone
  • Biphasic (30%): uniform spindle cells + pseudoglands
  • Poorly differentiated (<1%): small round blue cell tumor
  • Hyperchromatic nuclei, paradoxically low mitoses
  • Branching vessels, calcification
  • IHC
  • Keratin, EMA – usually focal and patchy
  • S100 in ~30%, SOX10 <10% (usually intraneural synovial sarcoma)
  • CD34 negative
  • Genetics
  • t(X;18), SS18-SSX1 –SSX2, -SSX4 fusion

Monophasic synovial sarcoma Monophasic synovial sarcoma

slide-13
SLIDE 13

13

Monophasic synovial sarcoma Monophasic synovial sarcoma Biphasic synovial sarcoma Biphasic synovial sarcoma

slide-14
SLIDE 14

14

Monophasic synovial sarcoma

Poorly differentiated synovial sarcoma

EMA Keratin SS18 break apart FISH Keratin

Take-home messages

  • 1. Do not diagnose diseases of joints (especially synovial

chondroma(tosis) without reviewing imaging. It could be a bone tumor.

  • 2. Just because it’s villous and synovial it does not mean it is

Pigmented Villonodular Synovitis

  • 3. Do not over-diagnose a desmin positive PVNS as

rhabdomyosarcoma

  • 4. Synovial sarcoma is a sarcoma but has nothing to do with

normal synovial cells